Search results
Results from the WOW.Com Content Network
This is a list of companies in digital therapeutics, a healthcare discipline that utilizes digital and Internet-based health technologies to make behavioral and lifestyle changes in patients. [ 1 ] [ 2 ] [ 3 ] Digital therapeutics is a relatively new discipline that uses digital implements like mobile devices , apps , sensors, the Internet of ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Image source: Getty Images. 1. AbbVie. AbbVie (NYSE: ABBV) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, including a strong focus on immunology ...
Many companies in the biotech industry performed well last year. Two in particular stood out: Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT). Both saw their shares more ...
The healthcare company posted another strong quarter of growth recently, with sales rising by 45% to $13.5 billion for the last three months of 2024. ... To say that Summit Therapeutics stock ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug candidate that aims to compete in an area of very high demand: weight loss.